Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Single Generational Injuries (1)
- Sex industry (1)
- Drug prace (1)
- Non-Tariff Barrier (1)
- Pharmaceuticals (1)
-
- HIV/AIDS (1)
- AIDS (1)
- Argentina (1)
- Technical Barriers to Trade (1)
- HIV (1)
- Public health (1)
- HIV in Thailand (1)
- Mediated Genome Editing (1)
- Risk groups (1)
- Thailand (1)
- Dispute Resolution (1)
- Pharmaceutical market (1)
- Popular film (1)
- Regulatory system (1)
- Clustered Regularly Interspaced Short Palindromic Repeat Associated System (1)
- Loss of Chance Doctrine (1)
- Developing countries (1)
- Multi-Generational Injuries (1)
- CRISPR/Cas-9 (1)
- TBT (1)
- Epidemic (1)
- Health policy (1)
- Fear of Harm Doctrine (1)
- Stigma (1)
- Tort Framework (1)
Articles 1 - 3 of 3
Full-Text Articles in Health Law and Policy
Crispr/Cas-9 Technologies: A Call For A New Form Of Tort, Kendall Lovell
Crispr/Cas-9 Technologies: A Call For A New Form Of Tort, Kendall Lovell
San Diego International Law Journal
Once relegated to the domains of science fiction, modern day scientists and researchers are poised on the precipice of making genome editing clinically available. Once introduced into a clinical setting the effects of an off-target mutation or germline edit will remain largely unknown until health issues arise later in life or in the following generation. The novelty of the injuries that will arise require a system that is able to balance the interests of physicians with single and multi-generational plaintiffs, while providing a realistic framework for courts to follow. This comment offers a brand-new context that accounts for these needs ...
Regulatory Marketing Approval For Pharmaceuticals As A Non-Tariff Barrier To Trade: Analysis Under The Wto's Agreement On Technical Barriers To Trade, Mary Hess Eliason
Regulatory Marketing Approval For Pharmaceuticals As A Non-Tariff Barrier To Trade: Analysis Under The Wto's Agreement On Technical Barriers To Trade, Mary Hess Eliason
San Diego International Law Journal
At a fundamental level, pharmaceuticals serve two roles: both as a cure for disease and as a product. As a cure for disease, a drug's value cannot be quantified because it saves lives. As a product, profit analysis shapes every step of a drug's progression to market. In least developed nations the barriers to drug access are not solely economic. National regulatory systems for market approval are being used to prevent external pharmaceutical manufacturers from participating in a national market. This article will address how the regulatory framework of pharmaceutical registration may serve as a barrier to trade ...
Affixing Blame: Ideologies Of Hiv/Aids In Thailand, Tarik Abdel-Monem
Affixing Blame: Ideologies Of Hiv/Aids In Thailand, Tarik Abdel-Monem
San Diego International Law Journal
This Article focuses on ideologies of the HIV/AIDS epidemic in Thailand, one of many nations where the HIV/AIDS pandemic has reached alarming levels. Not unlike other nations struggling with HIV/AIDS, an epidemic of stigma and blame has developed in Thailand with increasing rates of infection among the population. Understandings of whom to blame for the epidemic, and how to realize appropriate solutions, have likewise developed as the epidemic continues to persist and spread. This Article examines these ideologies and how they are mediated through the lens of popular culture in contemporary Thailand. It attempts to examine the ...